羚锐制药上周获融资净买入1677.77万元，居两市第477位

Summary of Key Points Core Viewpoint - The financing activities and capital flow of Lingrui Pharmaceutical indicate a mixed performance, with significant net buying but also notable outflows in recent days [1]. Financing Activities - Lingrui Pharmaceutical had a net financing inflow of 16.7777 million yuan last week, ranking 477th in the market [1]. - The total financing amount for the week was 117 million yuan, while the repayment amount was 99.8371 million yuan [1]. Capital Flow - Over the past 5 days, the main capital outflow from Lingrui Pharmaceutical was 52.8221 million yuan, with a decline of 6.54% during this period [1]. - In the last 10 days, the main capital outflow was 52.6537 million yuan, reflecting a decrease of 3.4% [1]. Company Profile - Lingrui Pharmaceutical, established in 1999, is located in Xinyang and primarily engages in the pharmaceutical manufacturing industry [1]. - The company has a registered capital of 567.115486 million yuan, which is also its paid-in capital [1]. - The legal representative of the company is Xiong Wei [1]. Investment and Intellectual Property - Lingrui Pharmaceutical has invested in 14 external enterprises and participated in 5,000 bidding projects [1]. - The company holds 287 trademark registrations and 249 patents, along with 356 administrative licenses [1].